These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
622 related articles for article (PubMed ID: 28241431)
1. The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism. Iizuka K Nutrients; 2017 Feb; 9(2):. PubMed ID: 28241431 [TBL] [Abstract][Full Text] [Related]
2. ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome. Oh AR; Sohn S; Lee J; Park JM; Nam KT; Hahm KB; Kim YB; Lee HJ; Cha JY Metabolism; 2018 Aug; 85():286-297. PubMed ID: 29669261 [TBL] [Abstract][Full Text] [Related]
3. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Iizuka K; Horikawa Y Endocr J; 2008 Aug; 55(4):617-24. PubMed ID: 18490833 [TBL] [Abstract][Full Text] [Related]
4. Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism. Lee HJ; Cha JY BMB Rep; 2018 Sep; 51(9):429-436. PubMed ID: 30158026 [TBL] [Abstract][Full Text] [Related]
5. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism. Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933 [TBL] [Abstract][Full Text] [Related]
6. ChREBP regulates fructose-induced glucose production independently of insulin signaling. Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460 [TBL] [Abstract][Full Text] [Related]
8. Intestinal, but not hepatic, ChREBP is required for fructose tolerance. Kim M; Astapova II; Flier SN; Hannou SA; Doridot L; Sargsyan A; Kou HH; Fowler AJ; Liang G; Herman MA JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263303 [TBL] [Abstract][Full Text] [Related]
9. [Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP]. Robichon C; Girard J; Postic C Med Sci (Paris); 2008 Oct; 24(10):841-6. PubMed ID: 18950580 [TBL] [Abstract][Full Text] [Related]
10. Treatment with myo-inositol attenuates binding of the carbohydrate-responsive element-binding protein to the ChREBP-β and FASN genes in rat nonalcoholic fatty liver induced by high-fructose diet. Shimada M; Ichigo Y; Shirouchi B; Takashima S; Inagaki M; Nakagawa T; Hayakawa T Nutr Res; 2019 Apr; 64():49-55. PubMed ID: 30802722 [TBL] [Abstract][Full Text] [Related]
11. The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases. Iizuka K Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769488 [TBL] [Abstract][Full Text] [Related]
12. Liver ChREBP Protects Against Fructose-Induced Glycogenic Hepatotoxicity by Regulating L-Type Pyruvate Kinase. Shi JH; Lu JY; Chen HY; Wei CC; Xu X; Li H; Bai Q; Xia FZ; Lam SM; Zhang H; Shi YN; Cao D; Chen L; Shui G; Yang X; Lu Y; Chen YX; Zhang WJ Diabetes; 2020 Apr; 69(4):591-602. PubMed ID: 31974143 [TBL] [Abstract][Full Text] [Related]
14. The Protective Role of the Carbohydrate Response Element Binding Protein in the Liver: The Metabolite Perspective. Agius L; Chachra SS; Ford BE Front Endocrinol (Lausanne); 2020; 11():594041. PubMed ID: 33281747 [TBL] [Abstract][Full Text] [Related]
15. Recent Progress on Fructose Metabolism-Chrebp, Fructolysis, and Polyol Pathway. Iizuka K Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049617 [TBL] [Abstract][Full Text] [Related]
16. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a. Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759 [TBL] [Abstract][Full Text] [Related]
17. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice. Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275 [TBL] [Abstract][Full Text] [Related]
18. Dietary supplementation with myo-inositol reduces hepatic triglyceride accumulation and expression of both fructolytic and lipogenic genes in rats fed a high-fructose diet. Shimada M; Hibino M; Takeshita A Nutr Res; 2017 Nov; 47():21-27. PubMed ID: 29241575 [TBL] [Abstract][Full Text] [Related]
19. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Ishii S; Iizuka K; Miller BC; Uyeda K Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15597-602. PubMed ID: 15496471 [TBL] [Abstract][Full Text] [Related]
20. Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1. Grefhorst A; Schreurs M; Oosterveer MH; Cortés VA; Havinga R; Herling AW; Reijngoud DJ; Groen AK; Kuipers F Biochem J; 2010 Dec; 432(2):249-54. PubMed ID: 20854262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]